| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |